In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
about
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapyCytochrome P450 3A1 mediates 2,2',4,4'-tetrabromodiphenyl ether-induced reduction of spermatogenesis in adult ratsTP53/MicroRNA Interplay in Hepatocellular CarcinomaIntegrated analysis of microarray data of atherosclerotic plaques: modulation of the ubiquitin-proteasome system.CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519dmiRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway.Let-7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora-B.Trophoblasts, invasion, and microRNA.Epigenetic alteration and microRNA dysregulation in cancerMicroRNAs, immune cells and pregnancy.C19MC microRNAs regulate the migration of human trophoblasts.MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.Involvement of miR-518c-5p to growth and metastasis in oral cancer.Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinomaMicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis.Placenta-specific miRNA (miR-512-3p) targets PPP3R1 encoding the calcineurin B regulatory subunit in BeWo cells.DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.MiR-519d-3p suppresses invasion and migration of trophoblast cells via targeting MMP-2.Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cellsMicroRNAs as potential biomarkers in cancer: opportunities and challengesNoncoding RNA as therapeutic targets for hepatocellular carcinoma.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.Exosome-delivered microRNAs of "chromosome 19 microRNA cluster" as immunomodulators in pregnancy and tumorigenesisMicroRNAs in placental health and diseaseGrouping miRNAs of similar functions via weighted information content of gene ontology.MicroRNAs as Biomarkers in Cancer.Function and clinical potential of microRNAs in hepatocellular carcinoma.Mechanisms of doxorubicin resistance in hepatocellular carcinomaMiR-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.Primate-specific miR-515 family members inhibit key genes in human trophoblast differentiation and are upregulated in preeclampsiaMicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
P2860
Q27005850-C3069E42-9503-4E43-8EF0-7C9AE40BFB15Q27314776-426384F0-FBEB-4758-9488-83D38E9C4628Q28073980-22036684-5F48-48FD-BA33-CF89AD9EE2E5Q30863548-81876C64-7F95-4D43-BAAB-798AE511D699Q33977066-6ACA1A72-D76C-4D47-AEBC-BF66A9E5C3E5Q33980238-8AD3E61A-9ABF-41C3-BD31-76DFF1998154Q34115364-C92BEDC0-9B56-41DA-8751-3B1F3AD0FD97Q34121288-C8B64A0B-5F67-409B-8173-BD2511FF0B7DQ34390117-2B06E12B-235F-4951-AACD-03B20F78D021Q34392645-E7A3E9A4-E664-4AC9-8E21-EDEAD03866C5Q34455623-E6F5AD4A-3E49-4495-88B3-5CF6287725D0Q34551672-89CEF118-2976-4702-B349-B31FE22C2668Q34704989-6AC2F90A-7548-4E39-92C8-7888A57E2A42Q34764792-68E1199E-2879-4477-A74A-9AE292B92C25Q34786512-FF05527F-8E60-4C07-B0FD-581423229E6DQ34984068-E2289A24-2CE6-45D9-957B-127BD9C371C8Q35023839-578675E7-8F62-411B-8827-3C516035C9F3Q35045834-5F1DCF4B-A69D-44D5-BC43-15325576C75BQ35197356-893A8BA6-E301-4490-80BF-4F6CDD6AEF32Q35214428-22CD3BDC-E51B-4662-96FA-CF091FAFEFDAQ35238444-197D232B-8BA6-4F07-B750-744B1AE9F049Q35271157-DF6F3814-FB5A-464A-A540-5B28ED872F86Q35592207-0A4D85B9-280B-4AA6-8849-062D4A769E20Q35715931-6488F530-7DC5-4111-90AC-2D76882D33AAQ35800606-004D4E78-F173-4F1D-B6D3-5CA8D6176AADQ35824254-D88D5184-2113-499B-BFA7-2B43ABDE6663Q36071469-28279C3B-E79E-47D8-A312-546615ADF0EFQ36118260-4DE8576B-1426-42D9-AFDD-38558C1E890FQ36268734-C54D835B-91CB-4E69-B9B4-1E0FE392C45BQ36335261-0A31A145-71B8-4CB9-8261-E73AE0C5CF8EQ36336198-6F61815A-9D6F-4846-8A27-9812076D7548Q36687760-FF4E8A46-C87F-46C6-B763-5CA408365D01Q36715101-76F9D97B-5E89-4886-B95A-EF18A5AA827EQ36855799-070932A0-0ED7-4C8B-8895-D0B6BABBE7DBQ36968033-ED4385BF-7CAB-434A-8B69-65C5E1CC04A2Q37268517-BE2931B7-F6DD-4B0B-BA13-EB1024F53AA6Q37357410-755433CC-A3AD-449C-B6B3-4A2142B0496BQ37417968-322B48C1-E566-40E3-BA7E-393253335E7EQ37607744-49887DEC-27F0-4FB0-927A-3F0935E06583Q37709050-CA2FD94F-853D-4C38-8B6F-146E51A4512E
P2860
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
In hepatocellular carcinoma mi ...... N1A/p21, PTEN, AKT3 and TIMP2.
@en
In hepatocellular carcinoma mi ...... N1A/p21, PTEN, AKT3 and TIMP2.
@nl
type
label
In hepatocellular carcinoma mi ...... N1A/p21, PTEN, AKT3 and TIMP2.
@en
In hepatocellular carcinoma mi ...... N1A/p21, PTEN, AKT3 and TIMP2.
@nl
prefLabel
In hepatocellular carcinoma mi ...... N1A/p21, PTEN, AKT3 and TIMP2.
@en
In hepatocellular carcinoma mi ...... N1A/p21, PTEN, AKT3 and TIMP2.
@nl
P2093
P50
P356
P1476
In hepatocellular carcinoma mi ...... N1A/p21, PTEN, AKT3 and TIMP2.
@en
P2093
Jessica Marinello
Luigi Bolondi
Matteo Cescon
Matteo Ravaioli
Silvia Sabbioni
Vilma Mantovani
P304
P356
10.1002/PATH.3995
P50
P577
2012-04-18T00:00:00Z